Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Lewis

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Chimia|December 2, 2014
SOM230: a new therapeutic modality for Cushing's diseaseIan Lewis, Herbert A Schmid, Rainer Kneuer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2019
Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation RecipientsMatthew B Roberts, Narin Bak, Li Yan A Wee, et al.
Journal of Molecular Neuroscience : MN|April 5, 2002
Drug design at peptide receptors: somatostatin receptor ligandsJason P Hannon, Caroline Nunn, Barbara Stolz, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 10, 2016
Development of a Behavior Change Intervention to Encourage Timely Cancer Symptom Presentation Among People Living in Deprived Communities Using the Behavior Change WheelStephanie Smits, Grace McCutchan, Fiona Wood, et al.
BMJ Open|May 7, 2013
A cross-sectional survey of healthcare professionals to determine what they believe constitutes 'specialist' care for teenage and young adult patients with cancerRebecca J Birch, Eva J A Morris, Robert M West, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising leadGebhard Thoma, Rolf Baenteli, Ian Lewis, et al.
Journal of the International Society of Sports Nutrition|September 23, 2018
Comparison of a sports-hydration drink containing high amylose starch with usual hydration practice in Australian rules footballers during intense summer trainingSinead Mary O'Connell, Richard John Woodman, Ian Lewis Brown, et al.
The Journal of Pathology. Clinical Research|February 26, 2021
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta-aggregationShujing Jane Lim, Kurinchi Gurusamy, Daniel O'Connor, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Chimia|December 2, 2014
SOM230: a new therapeutic modality for Cushing's diseaseIan Lewis, Herbert A Schmid, Rainer Kneuer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2019
Clinical Effectiveness of Conjugate Pneumococcal Vaccination in Hematopoietic Stem Cell Transplantation RecipientsMatthew B Roberts, Narin Bak, Li Yan A Wee, et al.
Journal of Molecular Neuroscience : MN|April 5, 2002
Drug design at peptide receptors: somatostatin receptor ligandsJason P Hannon, Caroline Nunn, Barbara Stolz, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 10, 2016
Development of a Behavior Change Intervention to Encourage Timely Cancer Symptom Presentation Among People Living in Deprived Communities Using the Behavior Change WheelStephanie Smits, Grace McCutchan, Fiona Wood, et al.
BMJ Open|May 7, 2013
A cross-sectional survey of healthcare professionals to determine what they believe constitutes 'specialist' care for teenage and young adult patients with cancerRebecca J Birch, Eva J A Morris, Robert M West, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising leadGebhard Thoma, Rolf Baenteli, Ian Lewis, et al.
Journal of the International Society of Sports Nutrition|September 23, 2018
Comparison of a sports-hydration drink containing high amylose starch with usual hydration practice in Australian rules footballers during intense summer trainingSinead Mary O'Connell, Richard John Woodman, Ian Lewis Brown, et al.
The Journal of Pathology. Clinical Research|February 26, 2021
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta-aggregationShujing Jane Lim, Kurinchi Gurusamy, Daniel O'Connor, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
Pageof 10